Pomaglumetad methionil HCl
Pomaglumetad methionil, also known as LY2140023, is a prodrug of LY-404039 and a a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. Pomaglumetad methionil is currently in clinical development as a potential new treatment for schizophrenia. LY2140023 is generally well tolerated and appears to have a low association with adverse events related to dopamine D2 receptor antagonism and with weight gain, which are commonly seen with current antipsychotics.
Supplier | Ace Therapeutics |
---|---|
Product # | SMD1650 |
CAS # | 635318-26-2 (HCl) |
Pricing | Customizable size, Inquiry |
Synonym | Pomaglumetad methionil HCl; LY2140023; LY-2140023; LY 2140023; LY2140023 monohydrate; Prodrug of LY-404039; |
Product Category | Lab-use Small Molecule Drugs |
Chemical Formula | C12H19ClN2O7S2 |
Molecular Weight | 402.861 |
Elemental Analysis | C, 35.78; H, 4.75; Cl, 8.80; N, 6.95; O, 27.80; S, 15.92 |
IUPAC/Chemical Name | (1R,4S,5S,6S)-4-(L-Methionylamino)-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid 2,2-dioxide hydrochloride |
InChi Key | KTYRTJLEXFSWRJ-LBMFEJOUSA-N |
InChi Code | InChI=1S/C12H18N2O7S2.ClH/c1-22-3-2-5(13)9(15)14-12(11(18)19)4-23(20,21)8-6(7(8)12)10(16)17;/h5-8H,2-4,13H2,1H3,(H,14,15)(H,16,17)(H,18,19);1H/t5-,6+,7+,8-,12-;/m0./s1 |
SMILES Code | O=C([C@]1(NC([C@H](CCSC)N)=O)CS([C@@]2([H])[C@H](C(O)=O)[C@@]12[H])(=O)=O)O.[H]Cl |
Appearance | Solid powder |
Purity | >98% (or refer to the Certificate of Analysis) |
Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
Solubility | Soluble in DMSO |
Shelf Life | >3 years if stored properly |
Drug Formulation | This drug may be formulated in DMSO |
Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
HS Tariff Code | 2934.99.9001 |